DrugPatentWatch Database Preview

Details for Patent: 8,846,695

Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,846,695 protect, and when does it expire?

Patent 8,846,695 protects JENTADUETO and TRADJENTA and is included in two NDAs.

This patent has sixteen patent family members in fifteen countries.

Summary for Patent: 8,846,695

Title:	Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy comprising a DPP-IV inhibitor
Abstract:	The present invention relates to the finding that certain DPP-4 inhibitors are particularly suitable for improving glycemic control in type 2 diabetes patients with inadequate glycemic control despite metformin therapy.
Inventor(s):	Dugi; Klaus (Dresden, DE)
Assignee:	Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE)
Application Number:	13/143,370
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,846,695
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 8,846,695

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Boehringer Ingelheim	JENTADUETO	linagliptin; metformin hydrochloride	TABLET;ORAL	201281-003	Jan 30, 2012		RX	Yes	Yes					Y	METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN COMBINATION WITH METFORMIN
Boehringer Ingelheim	JENTADUETO	linagliptin; metformin hydrochloride	TABLET;ORAL	201281-001	Jan 30, 2012		RX	Yes	No						METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN COMBINATION WITH METFORMIN
Boehringer Ingelheim	JENTADUETO	linagliptin; metformin hydrochloride	TABLET;ORAL	201281-002	Jan 30, 2012		RX	Yes	No						METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN COMBINATION WITH METFORMIN
Boehringer Ingelheim	TRADJENTA	linagliptin	TABLET;ORAL	201280-001	May 2, 2011		RX	Yes	Yes					Y	METHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN COMBINATION WITH METFORMIN

Foreign Priority and PCT Information for Patent: 8,846,695

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	09150159	Jan 7, 2009

PCT Information
PCT Filed	January 07, 2010	PCT Application Number:	PCT/EP2010/050103
PCT Publication Date:	July 15, 2010	PCT Publication Number:	WO2010/079197

International Family Members for US Patent 8,846,695

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	074990
Australia	2010204331
Brazil	PI1006144
Canada	2745039
Chile	2011001635